By employing peptide-dependent techniques to inhibit anti-apoptotic proteins like BCL-2, programmed cell Dying could be induced in cancer cells, in the long run leading to their demise. These focused methodologies show encouraging results in augmenting the performance of cancer therapy and boosting patient outcomes.Co-formulation with other permeat